Preliminary results of 90Y and 177Lu radiolabelling of ultra small rigid particles as multimodal probes

被引：0
|
作者：
Maurin, Michal [1 ]
Garnuszek, Piotr [1 ]
Mikolajczak, Renata [1 ]
Truillet, Charles [2 ]
Lux, F. [2 ]
Clabaut, A. [2 ]
Tillement, Oilivier [2 ]
机构：
[1] Radioisotope Ctr POLATOM NCBJ, Res Dept, Otwock, Poland
[2] Univ Lyon 1, CNRS, Lab Physicochim Mat Luminescents, Lyon, France
来源：
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS | 2013年 / 56卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
P150
引用
收藏
页码：S237 / S237
页数：1
相关论文
共 50 条
  • [41] Efficacy of the personalized, dosimetry-based PRRT treatment of patients with neuroendocrine tumors using [177Lu]Lu-DOTA-TATE or [177Lu]/[90Y]Lu/Y-DOTA-TATE mixture - the DUONEN multicenter study
    Opalinska, M.
    Mikolajczak, R.
    Kaminski, G.
    Dedecjus, M.
    Kowalska, A.
    Kolodziej, M.
    Saracyn, M.
    Garnuszek, P.
    Cieszykowska, I.
    Sowa-Staszczak, A.
    Hubalewska-Dydejczyk, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S369 - S369
  • [42] Clinical results of PRRT with 90Y-DOTATATE and 90Y/177Lu-DOTATATE - What is better for therapy?
    Kunikowska, Jolanta
    Krolicki, Leszek
    Mikolajczak, Renata
    Pawlak, Dariusz
    Hubalewska-Dydeiczyk, Alicja
    Sowa-Staszczak, Anna
    Kobylecka, Malgorzata
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [43] Familial SDHB gene mutation in disseminated non-hypoxiarelated malignant paraganglioma treated with [90Y]Y/[177Lu]Lu-DOTATATE
    Lon, Izabela
    Kunikowska, Jolanta
    Jedrusik, Piotr
    Gora, Jaroslaw
    Toutounchi, Sadegh
    Placha, Grzegorz
    Gaciong, Zbigniew
    INTRACTABLE & RARE DISEASES RESEARCH, 2021, 10 (03) : 207 - 213
  • [44] Clinical Results of PRRT with 90Y-DOTATATE and 90Y/177Lu-DOTATATE - What is Better for Therapy?
    Kunikowska, J.
    Mikolajczak, R.
    Pawlak, D.
    Hubalewska-Dydejczyk, A.
    Sowa-Staszczak, A.
    Kobylecka, M.
    NEUROENDOCRINOLOGY, 2009, 90 (01) : 121 - 121
  • [45] Comparison between clinical results of PRRT with 90Y-DOTA TATE and 90Y/177Lu-DOTATATE
    Kunikowska, J.
    Krolicki, L.
    Hubalewska-Dydejczyk, A.
    Mikolajczak, R.
    Sowa-Staszczak, A.
    Pawlak, D.
    Kobylecka, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S219 - S219
  • [46] Preparation of DOTA-dendron Cetuximab bioconjugates for radioimmunotherapy using 90Y, 177Lu and 67Cu
    Heldi, Jan-Martin
    Zenker, Martin
    Pietzsch, Hans-Juergen
    Bergmann, Ralf
    Steinbach, Joerg
    NUCLEAR MEDICINE AND BIOLOGY, 2010, 37 (06) : 696 - 697
  • [47] Anti-CD45 Radioimmunotherapy with 90Y but Not 177Lu Is Effective Treatment in a Syngeneic Murine Leukemia Model
    Orozco, Johnnie J.
    Balkin, Ethan R.
    Gooley, Ted A.
    Kenoyer, Aimee
    Hamlin, Donald K.
    Wilbur, D. Scott
    Fisher, Darrell R.
    Hylarides, Mark D.
    Shadman, Mazyar
    Green, Damian J.
    Gopal, Ajay K.
    Press, Oliver W.
    Pagel, John M.
    PLOS ONE, 2014, 9 (12):
  • [48] 125Sn is potentially better than 90Y for peptide receptor radionuclide therapy in combination with 177Lu
    Hanin, F.
    Walrand, S.
    Pauwels, S.
    Jamar, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S418 - S418
  • [49] Impressive Response to Tandem Treatment With [90Y]DOTATOC and [177Lu]DOTATOC in Grade 3 Pancreatic Neuroendocrine Carcinoma
    Lorenzoni, Alice
    Capozza, Antonella
    Artale, Salvatore
    Maccauro, Marco
    Seregni, Ettore Cesare
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (07) : 506 - 508
  • [50] Comparative study on DOTA-derivatized bombesin analog labeled with 90Y and 177Lu: in vitro and in vivo evaluation
    Koumarianou, Eftychia
    Mikolajczak, Renata
    Pawlak, Dariusz
    Zikos, Xhristos
    Bouziotis, Pinelopi
    Garnuszek, Piotr
    Karczmarczyk, Urszula
    Maurin, Michal
    Archimandritis, Spyridon C.
    NUCLEAR MEDICINE AND BIOLOGY, 2009, 36 (06) : 591 - 603
12345